Skip to main content
Premium Trial:

Request an Annual Quote

Paradigm Diagnostics Raises Additional $3M in Series B Round

NEW YORK (GenomeWeb) – Paradigm Diagnostics announced today that it has secured an additional $3 million in funding as part of a planned $7 million Series B round of financing.

The investment was made by New Science Ventures and follows a $3.5 million investment led by Mesa Verde Venture Partners in November. New Science Ventures Partner Grace Colón also joined Paradigm's board.

The company said that it intends to use the proceeds of the Series B round to accelerate commercial adoption of its flagship product, PCDx — a comprehensive targeted next-generation sequencing test designed to help personalize cancer treatments by identifying the underlying genomic and proteomic alterations in a tumor.

"This financing will help us to more broadly provide our solution to oncologists and patients," Paradigm President and CEO David Mallery said in a statement. "New Science Ventures' support also allows us to expand our cancer registry to build on the recent publication of our prospective clinical trial publication showing improved progression-free survival."

That study, which tracked results from the clinical use of PCDx in Indiana University's Health Precision Genomics Program between April 2014 and October 2015, showed that survival was significantly longer for patients who received genomically guided therapy than for those who did not.

Mallery told GenomeWeb that he expects Paradigm to receive an additional $500,000 investment by the end of March, closing out the Series B round.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.